Pharmacology, Toxicology and Pharmaceutical Science
Nanoparticle
100%
Malignant Neoplasm
100%
Immunotherapy
100%
Antibody Conjugate
100%
Cytokine
37%
Neoplasm
37%
Interleukin 2
37%
Quantum Dot
37%
Therapeutic Effect
25%
Side Effect
25%
Chemotherapy
12%
Biomaterial
12%
Biological Activity
12%
Anti-Inflammatory Drug
12%
Clinical Study
12%
Immune Checkpoint Inhibitor
12%
Adsorption
12%
Polyethylene Glycol
12%
Disease
12%
Calcium Ion
12%
Cause of Death
12%
Stabilizing Agent
12%
Tumor Microenvironment
12%
Biodistribution
12%
PEGylation
12%
Immunology and Microbiology
T Cell
100%
Polymerization
100%
Cancer Immunotherapy
100%
Antibody Conjugate
100%
Monospecific Antibody
20%
Transfer Cell
20%
Programmed Death-Ligand 1
15%
Surface Property
15%
Immunotherapy
15%
Interleukin 2
15%
T Cell Activation
10%
Immune System
10%
Cytokine
10%
Lifespan
10%
Antigen-Presenting Cell
5%
Solution and Solubility
5%
Biological Activity
5%
Antigen Specificity
5%
Cell Differentiation
5%
Proinflammatory Cytokine
5%
Gene Mutation
5%
Cancer Cell
5%
Cytotoxic Lymphocyte
5%
Cell Expansion
5%
Plasma Half Life
5%
PEGylation
5%
Biochemistry, Genetics and Molecular Biology
Polymerization
100%
T Cell
100%
Cancer Immunotherapy
100%
Monospecific Antibody
18%
Surface Property
13%
PD-L1
13%
Interleukin 2
13%
Lifespan
9%
Cytokine
9%
Cell Activation
9%
Solution and Solubility
4%
Clinical Study
4%
Immune Checkpoints
4%
Cancer Cell
4%
Biological Activity
4%
Adsorption
4%
Cellular Differentiation
4%
Gene Mutation
4%
Antigen Specificity
4%
Lymphocyte
4%
Antigen Presenting Cell
4%
Proinflammatory Cytokine
4%
Plasma Half Life
4%
Biodistribution
4%
Cell Expansion
4%
PEGylation
4%
Material Science
Polymer Nanoparticles
100%
T-Cells
100%
Tumor
18%
Nanoparticle
13%
Density
13%
Quantum Dot
13%
Biomaterial
4%
Polyethylene Glycol
4%
Stabilizer (Agent)
4%
Particle Property
4%
Polymer Chemistry
4%
Lymphocyte
4%
Keyphrases
T Cell Tracking
26%
Antibody Orientation
20%
Shaped Charge
6%
Ca2+ Sensing
6%
Anti-PD-L1 Antibody
6%
Labeling Agents
6%
Jurkat T Cells
6%
Oriented Antibody
6%
Therapeutic Evaluation
6%